{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:07:25Z","timestamp":1774120045624,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Invasive fungal disease (IFD) is a frequent and serious infectious complication in immunocompromised patients. Culture and cytology in bronchoalveolar lavage (BAL) have a high specificity but low sensitivity for the diagnosis of IFD as assessed by histology. Molecular methods are expected to allow a rapid diagnosis of IFD with a high sensitivity. We evaluated the diagnostic accuracy of conventional nested PCR in the bronchoalveolar fluid to diagnose IFD in severely immunocompromised patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Consecutive immunosuppressed patients undergoing bronchoscopy for suspected pulmonary infection in a tertiary care hospital were included. Patients were classified as having \u201cproven\u201d, \u201cprobable\u201d, \u201cpossible\u201d, and \u201cno\u201d IFD based on definitions of the European Organization for Research and Treatment of Cancer and National Institute of Allergy and Infectious Diseases (EORTC\/NIAID) and on clinical grounds. Conventional nested PCR for aspergillus fumigatus, flavus, niger, glaucus, terreus and tomarrii were applied to 2.5 ml bronchoalveolar fluid.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 191 patients were included. Mean age was 51 y, 61% were male. There were 129 patients with hematological conditions, 26 solid organ transplant recipients, 24 auto-immune disorders, and 12 HIV. According to the EORTC\/NIAID classification, there were 53 patients with potential IFD: 3 (2%) had proven, 8 (4%) probable, 42 (22%) possible and 138 (72%) no IFD. A total of 111 (58%) of the patients - 10 (90.9%) proven or probable IFD, 32 (76.2%) possible IFD and 69 (50%) \u201cno\u201d IFD) were on anti-fungal therapy at the time of bronchoscopy. Conventional nested PCR for Aspergillus was positive in 55 cases (28.8%). According to these results, sensitivity, specificity, PPV and NPV for \u201cproven\u201d IFD was 0%, 71%, 0%, 98%, respectively and \u201cprobable\u201d IFD was 36%, 72%, 7%, 95%, respectively. In 53 (28%) cases there was a strong clinical suspicion of IFD in the chest-x-ray and\/or chest-CT irrespective of the EORTC\/NIAID classification. However, from those, only 15 (28%) had a positive conventional nested PCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In our experience, conventional nested Aspergillus PCR in the BAL seems to be of limited usefulness for detection of invasive fungal disease in immunocompromised patients due to the limited sensitivity and specificity of the method.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-12-237","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T14:14:48Z","timestamp":1349187288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Michael","family":"Buess","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gieri","family":"Cathomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Halter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Grendelmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"issue":"6","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, et al: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002, 347 (6): 408-415. 10.1056\/NEJMoa020191.","journal-title":"N Engl J Med"},{"issue":"5","key":"2095_CR2","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1111\/j.1439-0507.2010.01903.x","volume":"54","author":"A Kim","year":"2011","unstructured":"Kim A, Nicolau DP, Kuti JL: Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses. 2011, 54 (5): e301-12. 10.1111\/j.1439-0507.2010.01903.x. Epub 2010 Jun 14","journal-title":"Mycoses"},{"issue":"11","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/sj.bmt.1702045","volume":"24","author":"F Reichenberger","year":"1999","unstructured":"Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT, Dalquen P, Gratwohl A, Tamm M: Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant. 1999, 24 (11): 1195-1199. 10.1038\/sj.bmt.1702045.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2095_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1086\/444462","volume":"41","author":"M Weisser","year":"2005","unstructured":"Weisser M, Rausch C, Droll A, Simcock M, Sendi P, Steffen I, Buitrago C, Sonnet S, Gratwohl A, Passweg J, et al: Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis. 2005, 41 (8): 1143-1149. 10.1086\/444462.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2095_CR5","first-page":"S86","volume":"93","author":"P Danpornprasert","year":"2010","unstructured":"Danpornprasert P, Foongladda S, Tscheikuna J: Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis. J Med Assoc Thai. 2010, 93 (Suppl 1): S86-93.","journal-title":"J Med Assoc Thai"},{"issue":"6","key":"2095_CR6","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1128\/JCM.00077-07","volume":"45","author":"CJ Clancy","year":"2007","unstructured":"Clancy CJ, Jaber RA, Leather HL, Wingard JR, Staley B, Wheat LJ, Cline CL, Rand KH, Schain D, Baz M, et al: Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol. 2007, 45 (6): 1759-1765. 10.1128\/JCM.00077-07.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2095_CR7","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1128\/jcm.33.12.3150-3153.1995","volume":"33","author":"PE Verweij","year":"1995","unstructured":"Verweij PE, Latge JP, Rijs AJMM, Melchers WJG, Depauw BE, Hoogkampkorstanje JAA, Meis JFGM: Comparison of Antigen-Detection and Pcr Assay Using Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis in Patients Receiving Treatment for Hematological Malignancies. J Clin Microbiol. 1995, 33 (12): 3150-3153.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2095_CR8","first-page":"99","volume":"20","author":"C Pazos","year":"2003","unstructured":"Pazos C, del Palacio A: Early diagnosis of invasive aspergillosis in neutropenic patients with bi-weekly serial screening of circulating galactomannan by Platelia Aspergillus. Rev Iberoam Micol. 2003, 20 (3): 99-102.","journal-title":"Rev Iberoam Micol"},{"issue":"2","key":"2095_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.diagmicrobio.2010.03.017","volume":"68","author":"ML Luong","year":"2010","unstructured":"Luong ML, Filion C, Labbe AC, Roy J, Pepin J, Cadrin-Tourigny J, Carignan S, Sheppard DC, Laverdiere M: Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2010, 68 (2): 132-139. 10.1016\/j.diagmicrobio.2010.03.017.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"2095_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1600-0609.2012.01806.x","volume":"89","author":"M Reinwald","year":"2012","unstructured":"Reinwald M, Spiess B, Heinz WJ, Vehreschild JJ, Lass-Florl C, Kiehl M, Schultheis B, Krause SW, Wolf HH, Bertz H, et al: Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. Eur J Haematol. 2012, 89 (2): 120-7. 10.1111\/j.1600-0609.2012.01806.x. Epub 2012 Jun 22","journal-title":"Eur J Haematol"},{"issue":"3","key":"2095_CR11","first-page":"103","volume":"20","author":"MD Moragues","year":"2003","unstructured":"Moragues MD, Amutio E, Garcia-Ruiz JC, Ponton J: Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis. Rev Iberoam Micol. 2003, 20 (3): 103-110.","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"2095_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, et al: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002, 34 (1): 7-14. 10.1086\/323335.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2095_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1378\/chest.99.3.562","volume":"99","author":"L Hernandez Blasco","year":"1991","unstructured":"Hernandez Blasco L, Sanchez Hernandez IM, Villena Garrido V, de Miguel Poch E, Nunez Delgado M, Alfaro Abreu J: Safety of the transbronchial biopsy in outpatients. Chest. 1991, 99 (3): 562-565. 10.1378\/chest.99.3.562.","journal-title":"Chest"},{"issue":"3","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1378\/chest.90.3.403","volume":"90","author":"M Ahmad","year":"1986","unstructured":"Ahmad M, Livingston DR, Golish JA, Mehta AC, Wiedemann HP: The safety of outpatient transbronchial biopsy. Chest. 1986, 90 (3): 403-405. 10.1378\/chest.90.3.403.","journal-title":"Chest"},{"issue":"3","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1378\/chest.129.3.734","volume":"129","author":"A Ernst","year":"2006","unstructured":"Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ: Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006, 129 (3): 734-737. 10.1378\/chest.129.3.734.","journal-title":"Chest"},{"issue":"3","key":"2095_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1164\/ajrccm.158.3.9801056","volume":"158","author":"F Reichenberger","year":"1998","unstructured":"Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schlapfer R, Stulz P, Perruchoud AP, Tichelli A, Gratwohl A, et al: Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med. 1998, 158 (3): 885-890.","journal-title":"Am J Respir Crit Care Med"},{"key":"2095_CR17","volume-title":"Chest","author":"C Nebiker","year":"2012","unstructured":"Nebiker C, Lardinois D, Junker L, Gambazzi F, Matt P, Habicht J, Halter J, Heim D, Stern M, Buser A, et al: Lung resection in hematologic patients with pulmoary invasive fungal disease. Chest. 2012, in press"},{"key":"2095_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2334-8-73","volume":"8","author":"PD Khot","year":"2008","unstructured":"Khot PD, Ko DL, Hackman RC, Fredricks DN: Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008, 8: 73-10.1186\/1471-2334-8-73.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2095_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1130-1406(07)70020-7","volume":"24","author":"FF Tuon","year":"2007","unstructured":"Tuon FF: A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol. 2007, 24 (2): 89-94. 10.1016\/S1130-1406(07)70020-7.","journal-title":"Rev Iberoam Micol"},{"issue":"10","key":"2095_CR20","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1128\/JCM.01466-10","volume":"48","author":"PL White","year":"2010","unstructured":"White PL, Perry MD, Loeffler J, Melchers W, Klingspor L, Bretagne S, McCulloch E, Cuenca-Estrella M, Finnstrom N, Donnelly JP, et al: Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol. 2010, 48 (10): 3753-3755. 10.1128\/JCM.01466-10.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2095_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/thx.2003.019836","volume":"59","author":"D Stolz","year":"2004","unstructured":"Stolz D, Chhajed PN, Leuppi JD, Brutsche M, Pflimlin E, Tamm M: Cough suppression during flexible bronchoscopy using combined sedation with midazolam and hydrocodone: a randomised, double blind, placebo controlled trial. Thorax. 2004, 59 (9): 773-776. 10.1136\/thx.2003.019836.","journal-title":"Thorax"},{"issue":"2","key":"2095_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1378\/chest.07-0175","volume":"132","author":"D Stolz","year":"2007","unstructured":"Stolz D, Stulz A, Muller B, Gratwohl A, Tamm M: BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host. Chest. 2007, 132 (2): 504-514. 10.1378\/chest.07-0175.","journal-title":"Chest"},{"issue":"12","key":"2095_CR23","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008, 46 (12): 1813-1821. 10.1086\/588660.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2095_CR24","first-page":"415","volume":"11","author":"G Cathomas","year":"1998","unstructured":"Cathomas G, Stalder A, McGandy CE, Mihatsch MJ: Distribution of human herpesvirus 8 DNA in tumorous and nontumorous tissue of patients with acquired immunodeficiency syndrome with and without Kaposi's sarcoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 1998, 11 (5): 415-420.","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"1","key":"2095_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1309\/RQ05PP9NEG6DADXR","volume":"119","author":"AS Pham","year":"2003","unstructured":"Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY: Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol. 2003, 119 (1): 38-44. 10.1309\/RQ05PP9NEG6DADXR.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2095_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/01.pas.0000186397.18206.1b","volume":"30","author":"V Zsikla","year":"2006","unstructured":"Zsikla V, Hailemariam S, Baumann M, Mund MT, Schaub N, Meier R, Cathomas G: Increased rate of Helicobacter pylori infection detected by PCR in biopsies with chronic gastritis. Am J Surg Pathol. 2006, 30 (2): 242-248. 10.1097\/01.pas.0000186397.18206.1b.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2095_CR27","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/cid\/cir185","volume":"52","author":"ML Luong","year":"2011","unstructured":"Luong ML, Clancy CJ, Vadnerkar A, Kwak EJ, Silveira FP, Wissel MC, Grantham KJ, Shields RK, Crespo M, Pilewski J, et al: Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011, 52 (10): 1218-1226. 10.1093\/cid\/cir185.","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"2095_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/cncr.23570","volume":"113","author":"M Shahid","year":"2008","unstructured":"Shahid M, Malik A, Bhargava R: Bronchogenic carcinoma and secondary aspergillosis\u2013common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis. Cancer. 2008, 113 (3): 547-558. 10.1002\/cncr.23570.","journal-title":"Cancer"},{"issue":"4","key":"2095_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1378\/chest.121.4.1171","volume":"121","author":"I Raad","year":"2002","unstructured":"Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M: Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest. 2002, 121 (4): 1171-1176. 10.1378\/chest.121.4.1171.","journal-title":"Chest"},{"issue":"4","key":"2095_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/321887","volume":"33","author":"D Buchheidt","year":"2001","unstructured":"Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M, Seifarth W, Leib-Moesch C, Hehlmann R: Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis. 2001, 33 (4): 428-435. 10.1086\/321887.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2095_CR31","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1128\/JCM.39.6.2338-2340.2001","volume":"39","author":"MP Hayette","year":"2001","unstructured":"Hayette MP, Vaira D, Susin F, Boland P, Christiaens G, Melin P, De Mol P: Detection of Aspergillus species DNA by PCR in bronchoalveolar lavage fluid. J Clin Microbiol. 2001, 39 (6): 2338-2340. 10.1128\/JCM.39.6.2338-2340.2001.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2095_CR32","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1128\/JCM.37.12.3865-3871.1999","volume":"37","author":"H Skladny","year":"1999","unstructured":"Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mosch C, Hehlmann R: Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol. 1999, 37 (12): 3865-3871.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2095_CR33","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.0007-1048.2002.03337.x","volume":"116","author":"D Buchheidt","year":"2002","unstructured":"Buchheidt D, Baust C, Skladny H, Baldus M, Brauninger S, Hehlmann R: Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br J Haematol. 2002, 116 (4): 803-811. 10.1046\/j.0007-1048.2002.03337.x.","journal-title":"Br J Haematol"},{"issue":"9","key":"2095_CR34","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/jac\/dks208","volume":"67","author":"M Reinwald","year":"2012","unstructured":"Reinwald M, Hummel M, Kovalevskaya E, Spiess B, Heinz WJ, Vehreschild JJ, Schultheis B, Krause SW, Claus B, Suedhoff T, et al: Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother. 2012, 67 (9): 2260-7. 10.1093\/jac\/dks208. Epub 2012 Jun 27","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2095_CR35","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/429921","volume":"40","author":"KA Marr","year":"2005","unstructured":"Marr KA, Laverdiere M, Gugel A, Leisenring W: Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005, 40 (12): 1762-1769. 10.1086\/429921.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2095_CR36","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1128\/JCM.41.9.4304-4311.2003","volume":"41","author":"K Rantakokko-Jalava","year":"2003","unstructured":"Rantakokko-Jalava K, Laaksonen S, Issakainen J, Vauras J, Nikoskelainen J, Viljanen MK, Salonen J: Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis. J Clin Microbiol. 2003, 41 (9): 4304-4311. 10.1128\/JCM.41.9.4304-4311.2003.","journal-title":"J Clin Microbiol"},{"issue":"Spec No 1","key":"2095_CR37","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.annpat.2009.07.053","volume":"29","author":"G Cathomas","year":"2009","unstructured":"Cathomas G: Molecular diagnostic in infectious disease pathology: an update. Ann Pathol. 2009, 29 (Spec No 1): S19-21.","journal-title":"Ann Pathol"},{"issue":"19","key":"2095_CR38","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","volume":"339","author":"N Regamey","year":"1998","unstructured":"Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P: Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med. 1998, 339 (19): 1358-1363. 10.1056\/NEJM199811053391903.","journal-title":"N Engl J Med"},{"key":"2095_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-1596-5-1","volume":"5","author":"V Hofman","year":"2010","unstructured":"Hofman V, Dhouibi A, Butori C, Padovani B, Gari-Toussaint M, Garcia-Hermoso D, Baumann M, Venissac N, Cathomas G, Hofman P: Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient. Diagn Pathol. 2010, 5: 1-10.1186\/1746-1596-5-1.","journal-title":"Diagn Pathol"},{"issue":"3","key":"2095_CR40","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1378\/chest.119.3.838","volume":"119","author":"M Tamm","year":"2001","unstructured":"Tamm M, Traenkle P, Grilli B, Soler M, Bolliger CT, Dalquen P, Cathomas G: Pulmonary cytomegalovirus infection in immunocompromised patients. Chest. 2001, 119 (3): 838-843. 10.1378\/chest.119.3.838.","journal-title":"Chest"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-237\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:58:26Z","timestamp":1630529906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-237","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]},"assertion":[{"value":"26 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"237"}}